Results 61 to 70 of about 2,075 (191)
Adverse Drug Reaction Study of Botulinum Toxin‐A in the Real World
ABSTRACT Background Despite the increasing use of botulinum toxin type A (BoNT‐A) in aesthetic and therapeutic applications, its real‐world adverse drug reaction (ADR) profile remains incompletely characterized. Current evidence relies largely on small‐scale clinical observations rather than large, systematic analyses.
Jiaxu Gu +9 more
wiley +1 more source
A human bispecific antibody neutralizes botulinum neurotoxin serotype A [PDF]
Botulinum neurotoxin (BoNT) shows high lethality and toxicity, marking it as an important biological threat. The only effective post-exposure therapy is botulinum antitoxin; however, such products have great potential for improvement. To prevent or treat
Lei Chen +10 more
core +1 more source
BackgroundThe increasing cosmetic use of botulinum toxin has been accompanied by poisoning events related to inappropriate administration, including excessive dosing, unapproved or unverifiable products, self-injection, and procedures performed outside ...
Yu-quan Chen +5 more
doaj +1 more source
Botulism after intragastric botulinum toxin injections for weight reduction [PDF]
Although-considering the risk-benefit ratio-botulinum neurotoxin A (BoNT/A) is unequivocally recommended to treat severe neurological diseases such as dystonia, this has not yet been determined for its endoscopic intragastric injection aimed at weight ...
Wunderlich, Gilbert +17 more
core +1 more source
A BEVERAGE-BORNE ATTACK WITH BOTULINUM TOXIN [PDF]
Terrorists contaminated beer tanks of an amusement park supply chain with Botulinum toxin. The amusement park delivers beer to its restaurants and coffee shops by a pipeline network supplied from beer tanks which are fed by tanker-trucks. There are 30000
Chen, Wanying, Guinet, A.
core +4 more sources
A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins
The pharmacopeia mouse neutralization assay (PMNA) is the standard method for determining the potency of pharmaceutical botulinum antitoxins. However, a PMNA requires a large number of mice, and, thus, an alternative in vitro method to replace it is needed.
Eran, Diamant +11 more
openaire +3 more sources
Research on the mechanism of OPR restoring intestinal epithelial cell (IEC) structure and function in inflammatory bowel disease (IBD) treatment. (A) Schematic diagram of OPR structure and the rate of GP release under different conditions. (B) Schematic diagram of OPR targeting IBD colonic lesions through charge interaction.
Wensheng Chen +7 more
wiley +1 more source
Intestinal Toxemia Botulism in 3 Adults, Ontario, Canada, 2006–2008
Five cases of intestinal toxemia botulism in adults were identified within an 18-month period in or near Toronto, Ontario, Canada. We describe findings for 3 of the 5 case-patients.
Yolanda D. Sheppard +17 more
doaj +1 more source
Type C botulism outbreak in free-ranging waterfowl in Goiás
: Botulism is generally a fatal disease caused by ingestion of neurotoxins produced by Clostridium botulinum. The present study describes the epidemiological, clinical, and laboratory aspects of a type C botulism outbreak in free-living aquatic birds ...
Andressa S. Martins +7 more
doaj +1 more source
Clostridium BotulinumTypes A and B Toxin-Antitoxin Reactions [PDF]
SummaryC. botulinumtypes A and B toxins required larger amounts of antitoxin for neutralization when fractions of the test dose of toxin were used than would be expected.The degree of this dilution effect, i.e. the dilution ratio, varied with different sera.
openaire +2 more sources

